Skip to Content

Viekira Pak

In the US, Viekira Pak (dasabuvir/ombitasvir/paritaprevir/ritonavir systemic) is a member of the drug class antiviral combinations and is used to treat Hepatitis C.

US matches:

Ingredient matches for Viekira Pak

Dasabuvir

Dasabuvir Sodium Monohydrate (a derivative of Dasabuvir) is reported as an ingredient of Viekira Pak in the following countries:

  • United States

Ombitasvir

Ombitasvir is reported as an ingredient of Viekira Pak in the following countries:

  • United States

Paritaprevir

Paritaprevir is reported as an ingredient of Viekira Pak in the following countries:

  • United States

Ritonavir

Ritonavir is reported as an ingredient of Viekira Pak in the following countries:

  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide